Open Access Open Access  Restricted Access Subscription or Fee Access

A Brief review on Safety of intra-articular cell-therapy with culture-expanded stem cells

Imran Baig, Meekanti Manasa Rekha, Rinku Mathppan

Abstract


An important goal of stem cell research in orthopaedics is to develop clinically relevant techniques that could be applied to heal cartilage or joint pathology. Stem cell treatment in orthopaedics for joint pathology is promising since these cells have the ability to modulate different processes in the various tissues of the joint simultaneously. The non life-threatening nature of musculoskeletal system disorders makes safety of stem cell therapy a necessary prerequisite.


Keywords


Culture-expanded; Humans; Intra-articular; Safety; Stem cells.

Full Text:

PDF

References


J. Wagner, T. Kean, R. Young, J.E. Dennis, A.I. Caplan. Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol. 2009:20(5):531-536pp.

J.B. Moseley Jr., A.F. Anderson, J.E. Browne, B.R. Mandelbaum, L.J. Micheli, F. Fu, et al. Long-term durability of autologous chondrocyte implantation: a multicenter, observational study in US patients. Am J Sports Med, 2010:38(2):238-246pp.

L. Peterson, H.S. Vasiliadis, M. Brittberg, A. Lindahl. Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med. 2010:38(6):1117-1124pp.

K. Pelttari, H. Lorenz, S. Boeuf, M.F. Templin, O. Bischel, K. Goetzke, et al. Secretion of matrix metalloproteinase 3 by expanded articular chondrocytes as a predictor of ectopic cartilage formation capacity in vivo. Arthritis Rheum, 2008:58(2):467-474pp.

G.A. Matricali, G.P. Dereymaeker, F.P. Luyten. Donor site morbidity after articular cartilage repair procedures: a review. Acta Orthop Belg. 2010:76(5):669-674pp. 6. G. Liu, H. Kawaguchi, T. Ogasawara, Y. Asawa, J. Kishimoto, T. Takahashi, et al. Optimal combination of soluble factors for tissue engineering of permanent cartilage from cultured human chondrocytes. J Biol Chem. 2007:282(28):20407-20415pp.

P.K. Bos, M.L. Melle, G.J.V.M. Osch. Articular cartilage repair and the evolving role of regenerative medicine. Open Access Surg. 2010:3:109-122pp.

J. Pak. Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads Pain. Physician. 2012:15(1):75-85pp.

C.J. Centeno, J.R. Schultz, M. Cheever, M. Freeman, S. Faulkner, B. Robinson, et al. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther. 2011:6(4):368-378pp.

V. Gangji, V. De Maertelaer, J.P. Hauzeur. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011: 49(5):1005-1009pp.

S. Giannotti, V. Bottai, M. Ghilardi, G. Dell'osso, R. Fazzi, L. Trombi, et al. Treatment of pseudoarthrosis of the upper limb using expanded mesenchymal stem cells: a pilot study. Eur Rev Med Pharmacol Sci. 2013:17(2):224-227pp.

P. Pastides, M. Chimutengwende-Gordon, N. Maffulli, W. Khan. Stem cell therapy for human cartilage defects: a systematic review. Osteoarthritis Cartilage. 2013:21(5):646-654pp.

D.M. Clifford, S.A. Fisher, S.J. Brunskill, C. Doree, A. Mathur, S. Watt, et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2012:(2):CD006536pp.

K. Le Blanc, F. Frassoni, L. Ball, F. Locatelli, H. Roelofs, I. Lewis, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008:371(9624):1579-1586pp.

M. Duijvestein, A.C. Vos, H. Roelofs, M.E. Wildenberg, B.B. Wendrich, H.W. Verspaget, et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut. 2010:59(12):1662-1669pp.


Refbacks

  • There are currently no refbacks.